(1)
ARTIFICIAL INTELLIGENCE-DRIVEN EARLY DETECTION OF NEUROPSYCHIATRIC DISORDERS USING MULTIMODAL BIOMARKERS: INTEGRATING NEUROIMAGING, GENOMIC, AND CLINICAL DATA FOR PRECISION DIAGNOSTICS. GCM 2026, 1 (4), 160-183.